6 November, 2015
This presentation describes key clinical features of OSA, its prevalence, ethnic and geographical distribution in New Zealand, disease burden, societal cost, and the cost effectiveness of current treatments. Presented to Respiratory Conference New Zealand in November 2015.
Best Practice Advocacy Centre New Zealand.
30 November, 2012
Obstructive sleep apnoea is reported to affect 4% of adult males and 2% of adult females. In New Zealand, it is twice as common in Māori adults males compared to non-Māori.
Bakker, J., O’Keeffe, K., Neill, A., & Campbell, A.
30 April, 2011
This study investigated the influence of ethnicity on adherence with continuous positive airway pressure (CPAP) in a sample of 126 New Zealand patients. The authors concluded that disparity in CPAP adherence demonstrated between Māori and non-Māori can be explained in part by lower education levels and socioeconomic status.
Gander, P., Scott, G., Mihaere, K., & Scott, H.
27 August, 2010
Aim: To estimate the societal costs of obstructive sleep apnoea syndrome (OSAS) in New Zealand and develop a simulation tool to evaluate treatment options.
Mihaere, K., Harris, R., Gander, P., Reid, P., Purdie, G., Robson, B., et al.
31 July, 2009
Study Objectives: Examine the distribution of symptoms and risk factors, and estimate the prevalence of obstructive sleep apnea (OSA) among Māori and non-Māori New Zealanders.
Professor Lutz Beckert
6 June, 2018
Respiratory research review featuring research on obstructive sleep apnoea.